Quarterly report pursuant to Section 13 or 15(d)

REVENUE

v3.23.2
REVENUE
6 Months Ended
Jun. 30, 2023
REVENUE  
REVENUE

3. REVENUE

The Company disaggregates revenue from contracts with customers by revenue stream as this depicts the nature, amount, timing and uncertainty of its revenue and cash flows as affected by economic factors. Commercial insurance consists of neuromonitoring cases whereby a patient has healthcare insurance that we bill. Facility billing consists of neuromonitoring cases whereby the Company has an agreement to bill the medical facility for patients that do not have health care insurance.  

The Company’s revenue disaggregated by payor is as follows (in thousands):

Three Months Ended June 30, 

Six Months Ended June 30, 

2023

    

2022

2023

    

2022

  

 

  

  

 

  

Commercial insurance

$

(243)

$

(306)

$

1,553

$

2,518

Facility billing

1,216

1,227

2,528

2,272

Managed service agreements and other

570

724

1,014

1,556

Total

$

1,543

$

1,645

$

5,095

$

6,346

The negative revenue for the three months ended June 30, 2023 and 2022 is related to implicit pricing concessions, including subsequent revisions of accrual rate estimates for services performed in previous periods, being greater than revenue generated for the period.  

Accounts Receivable

A summary of the accounts receivable, net, by revenue stream is as follows (in thousands):

June 30, 

December 31,

    

2023

    

2022

Technical service

$

1,844

 

$

3,072

Professional service

7,094

11,829

Other

 

150

 

242

Total accounts receivable, net

$

9,088

$

15,143

The concentration of accounts receivable, net, by payor as a percentage of total accounts receivable is as follows:

As of June 30,

As of December 31,

2023

    

2022

 

  

Commercial insurance

86

%

84

%

Facility billing

9

%

9

%

Other

5

%

7

%

Total

 

100

%

100

%